Loading...
XNAS
XRAY
Market cap3.19bUSD
Jul 14, Last price  
16.00USD
1D
-1.30%
1Q
27.49%
Jan 2017
-72.28%
Name

DENTSPLY SIRONA Inc

Chart & Performance

D1W1MN
No data to show
P/E
—
P/S
0.84
EPS
—
Div Yield, %
3.00%
Shrs. gr., 5y
-1.97%
Rev. gr., 5y
-1.20%
Revenues
3.79b
-4.34%
1,715,135,0001,810,496,0002,009,833,0002,193,723,0002,159,916,0002,221,014,0002,537,718,0002,928,429,0002,950,770,0002,922,620,0002,674,300,0003,745,300,0003,993,400,0003,986,300,0004,029,200,0003,342,000,0004,251,000,0003,922,000,0003,965,000,0003,793,000,000
Net income
-910m
L+589.39%
45,413,000223,718,000259,654,000283,869,000274,258,000265,708,000244,520,000314,213,000313,192,000322,854,000251,200,000429,900,000-1,573,000,000-1,011,000,000262,900,000-83,000,000411,000,000-950,000,000-132,000,000-910,000,000
CFO
461m
+22.28%
232,769,000271,855,000387,697,000335,981,000362,489,000362,324,000393,469,000369,685,000417,846,000560,401,000497,400,000563,400,000601,900,000499,800,000632,800,000635,000,000657,000,000517,000,000377,000,000461,000,000
Dividend
Sep 27, 20240.16 USD/sh
Earnings
Jul 29, 2025

Profile

Dentsply Sirona, Inc. engages in the design, manufacture, sales, and distribution of professional dental products and technologies. The company is headquartered in Charlotte, North Carolina and currently employs 16,400 full-time employees. The firm develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. The company operates through two segments: Dental and Healthcare Consumables, and Technologies. The dental industry encompasses the diagnosis, treatment and prevention of disease and ailments of the teeth, gums and supporting bone. Its principal dental product categories are dental consumable products, dental laboratory products, dental specialty products and dental equipment. Additionally, its consumable medical device products are used for urological and surgical applications. These products are produced by the Company in the United States and internationally and are distributed throughout the world under various brand names, including ANKYLOS, AQUASIL ULTRA, ARTICADENT, ATLANTIS, CALIBRA, CAULK, CAVITRON, CELTRA, DELTON, DENTSPLY, DETREY and DYRACT.
URL
https://www.dentsplysirona.com/
IPO date
Aug 12, 1987
Employees
15,000
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
3,793,000
-4.34%
3,965,000
1.10%
3,922,000
-7.74%
Cost of revenue
2,000,000
3,683,000
3,558,000
Unusual Expense (Income)
NOPBT
1,793,000
282,000
364,000
NOPBT Margin
47.27%
7.11%
9.28%
Operating Taxes
(26,000)
(43,000)
(105,000)
Tax Rate
NOPAT
1,819,000
325,000
469,000
Net income
(910,000)
589.39%
(132,000)
-86.11%
(950,000)
-331.14%
Dividends
(126,000)
(116,000)
(104,000)
Dividend yield
3.27%
1.54%
1.52%
Proceeds from repurchase of equity
(250,000)
(300,000)
(144,000)
BB yield
6.48%
3.98%
2.10%
Debt
Debt current
549,000
378,000
118,000
Long-term debt
1,768,000
2,046,000
2,124,000
Deferred revenue
Other long-term liabilities
415,000
730,000
399,000
Net debt
2,045,000
2,090,000
1,852,000
Cash flow
Cash from operating activities
461,000
377,000
517,000
CAPEX
(180,000)
(149,000)
(149,000)
Cash from investing activities
(197,000)
(89,000)
(138,000)
Cash from financing activities
(302,000)
(307,000)
(329,000)
FCF
2,057,000
143,000
328,000
Balance
Cash
272,000
334,000
365,000
Long term investments
25,000
Excess cash
82,350
135,750
193,900
Stockholders' equity
(1,561,000)
(427,000)
(168,000)
Invested Capital
6,145,000
6,750,000
6,426,000
ROIC
28.21%
4.93%
6.62%
ROCE
38.04%
4.46%
5.56%
EV
Common stock shares outstanding
203,200
212,000
215,500
Price
18.98
-46.67%
35.59
11.78%
31.84
-42.93%
Market cap
3,856,736
-48.88%
7,545,080
9.96%
6,861,520
-44.15%
EV
5,902,736
9,636,080
8,714,520
EBITDA
2,142,000
625,000
692,000
EV/EBITDA
2.76
15.42
12.59
Interest
69,000
81,000
60,000
Interest/NOPBT
3.85%
28.72%
16.48%